JP2024530059A5 - - Google Patents
Info
- Publication number
- JP2024530059A5 JP2024530059A5 JP2024532370A JP2024532370A JP2024530059A5 JP 2024530059 A5 JP2024530059 A5 JP 2024530059A5 JP 2024532370 A JP2024532370 A JP 2024532370A JP 2024532370 A JP2024532370 A JP 2024532370A JP 2024530059 A5 JP2024530059 A5 JP 2024530059A5
- Authority
- JP
- Japan
- Prior art keywords
- application
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230161P | 2021-08-06 | 2021-08-06 | |
| US63/230,161 | 2021-08-06 | ||
| PCT/US2022/039694 WO2023015027A1 (en) | 2021-08-06 | 2022-08-08 | Process for producing personalized cancer immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530059A JP2024530059A (ja) | 2024-08-14 |
| JP2024530059A5 true JP2024530059A5 (https=) | 2025-08-18 |
Family
ID=85154820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532370A Pending JP2024530059A (ja) | 2021-08-06 | 2022-08-08 | 個別化されたがん免疫療法を創出するためのプロセス |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250073323A1 (https=) |
| EP (1) | EP4380619A4 (https=) |
| JP (1) | JP2024530059A (https=) |
| KR (1) | KR20240045239A (https=) |
| CN (1) | CN117999097A (https=) |
| CA (1) | CA3227687A1 (https=) |
| WO (1) | WO2023015027A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120314588B (zh) * | 2025-05-21 | 2025-10-17 | 成都蓉生药业有限责任公司 | 一种人免疫球蛋白抗体依赖性细胞介导的吞噬作用生物学活性的检测方法和检测试剂盒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017022845A2 (pt) * | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| ES2875274T3 (es) * | 2015-11-02 | 2021-11-10 | Hoffmann La Roche | Procedimientos de preparación de formas fucosiladas y afucosiladas de una proteína |
| US20210147550A1 (en) * | 2017-08-18 | 2021-05-20 | Joshua Michael Francis | Antigen-binding proteins targeting shared antigens |
| AU2020387167B2 (en) * | 2019-11-20 | 2024-10-24 | Immunitybio, Inc. | Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment |
-
2022
- 2022-08-08 KR KR1020247006389A patent/KR20240045239A/ko active Pending
- 2022-08-08 US US18/293,994 patent/US20250073323A1/en active Pending
- 2022-08-08 EP EP22853992.0A patent/EP4380619A4/en active Pending
- 2022-08-08 CN CN202280064622.3A patent/CN117999097A/zh active Pending
- 2022-08-08 CA CA3227687A patent/CA3227687A1/en active Pending
- 2022-08-08 JP JP2024532370A patent/JP2024530059A/ja active Pending
- 2022-08-08 WO PCT/US2022/039694 patent/WO2023015027A1/en not_active Ceased